atai Life Sciences poised to create value as psychedelic therapies gain traction, analysts believe

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) has a pipeline of psychedelic and non-psychedelic drug assets that are poised to create value, analysts at...

Related Keywords

,Beckley Psytech ,Life Sciences ,Drug Administration ,Psychopharmacologic Drugs Advisory Committee On ,Drugs Advisory Committee ,Big Pharma ,